Opinion|Videos|August 12, 2024
Overcoming Immunotherapy Resistance: Identifying Non-Responders and Novel Approaches
The panel shares clinical practices for overcoming immunotherapy resistance in patients with non-small cell lung cancer.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What gaps remain in identifying likely non-responders to immunotherapy to guide alternative treatments?
- How does the toxicity profile of immuno-oncology regimens compare to standard chemotherapy options?
- Are there ongoing trials or research on novel combination approaches to overcome resistance and improve immunotherapy efficacy?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?
2
FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication
3
What Comes After Anti-VEGF in Wet AMD: Arshad Khanani, MD
4
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
5